Biblioteca Humberto Rosselli Quijano
Resultado de la búsqueda
2 búsqueda de la palabra clave 'Antipsicóticos, Atropina, Enfermedades del sistema nervioso autónomo, Antagonistas colinérgicos, Clozapina, Antagonistas muscarínicos, Pirenzepina, Trastornos psicóticos.'
Refinar búsqueda Générer le flux rss de la recherche
Lien permanent de la recherche
Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine en Journal of Clinical Psychopharmacology, Año 2000 - Vol. 20 - No. 3 (Junio)Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine / K. N. R. Chengappa en Journal of Clinical Psychopharmacology, Año 2000 - Vol. 20 - No. 3 (Junio)
[artículo]
Título : Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine Tipo de documento: texto impreso Autores: K. N. R. Chengappa, Autor ; Bruce G. Pollock, Autor ; Haranath Parepally, Autor Fecha de publicación: 2023 Artículo en la página: pp. 311-316 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Atropina, Enfermedades del sistema nervioso autónomo, Antagonistas colinérgicos, Clozapina, Antagonistas muscarínicos, Pirenzepina, Trastornos psicóticos. Resumen: This study evaluated anticholinergic effects among patients with schizophrenia, schizoaffective disorder, or bipolar I disorder who were receiving either olanzapine (N = 12) or clozapine (N = 12) at standard clinical doses in a naturalistic setting. Serum anticholinergic levels were determined in adult male and female subjects using a radioreceptor binding assay. The Udvalg for Kliniske Undersogelser Scale was used to evaluate anticholinergic side effects clinically, and the Mini-Mental State Examination provided a global cognitive measure. Link: ./index.php?lvl=notice_display&id=31197
in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 3 (Junio) . - pp. 311-316[artículo] Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine [texto impreso] / K. N. R. Chengappa, Autor ; Bruce G. Pollock, Autor ; Haranath Parepally, Autor . - 2023 . - pp. 311-316.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 3 (Junio) . - pp. 311-316
Palabras clave: Antipsicóticos, Atropina, Enfermedades del sistema nervioso autónomo, Antagonistas colinérgicos, Clozapina, Antagonistas muscarínicos, Pirenzepina, Trastornos psicóticos. Resumen: This study evaluated anticholinergic effects among patients with schizophrenia, schizoaffective disorder, or bipolar I disorder who were receiving either olanzapine (N = 12) or clozapine (N = 12) at standard clinical doses in a naturalistic setting. Serum anticholinergic levels were determined in adult male and female subjects using a radioreceptor binding assay. The Udvalg for Kliniske Undersogelser Scale was used to evaluate anticholinergic side effects clinically, and the Mini-Mental State Examination provided a global cognitive measure. Link: ./index.php?lvl=notice_display&id=31197